Circulating immune complexes in the idiopathic interstitial pneumonias.
about
Autoantibodies in cryptogenic fibrosing alveolitisImmune complexes and antibodies to BCG in sera from patients with mycobacterial infectionsImmunopathology of the lung: a reviewNew perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitisCirculating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression.Oxidants/antioxidants in idiopathic pulmonary fibrosis.Complement system in lung disease.Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.Pulmonary response of fifth component of complement-sufficient and -deficient mice to hyperoxia.Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disordersInvolvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis.Progressive dyspnea in a 39-year-old housewifeFibrosing alveolitisMicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I.The effects of bleomycin on alveolar macrophage growth factor secretion.Immune complexes in human diseases: a reviewLeukocytes in chemotactic-fragment-induced lung inflammation. Vascular emigration and alveolar surface migration.Immune complex injury of the lungInflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.The significance of antinuclear and DNA antibodies in cryptogenic fibrosing alveolitis.Dermatomyositis and rapidly progressive fibrosing alveolitis.Prognosis of cryptogenic fibrosing alveolitis.Cutaneous vasculitis and immune complexes in severe bronchiectasis.Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivityRapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitisHyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.Pulmonary gamma interferon production in patients with fibrosing alveolitis.Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome?Complement inhibition decreases early fibrogenic events in the lung of septic baboons.A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice.Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features.Cryptogenic fibrosing alveolitis: clinical features and their influence on survivalBronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapyCryptogenic fibrosing alveolitis and lung cancer.Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survivalResponse to methotrexate in fibrosing alveolitis associated with connective tissue diseaseImmunologic concepts relating to the pathogenesis of diffuse interstitial lung diseases (emphasizing granulomatous forms and idiopathic pulmonary fibrosis).Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
P2860
Q24791773-B3EFDFA2-2D14-4D1E-8334-1FE9D0AD694FQ28390171-A16A7E41-735B-4A87-93A2-5BD40B0D20F0Q28397007-98E72A8A-47BD-4598-8E6C-1950AA86D725Q33604630-D4A19D2C-9298-487C-841D-FC27CB7A0326Q33604682-195D6ACB-0D60-445A-83D1-11D93E865565Q33712467-E957DB70-9C42-4CF8-BD30-CDD7E3AFEE46Q33821300-8FF088A9-CACB-4307-B31C-27B679C5267EQ34305533-D5AABA49-F4EC-4846-A9FC-2431D03DA6B3Q34365488-A173A4D4-3BE5-4737-AC4E-44670FCD31EFQ34575404-9552231E-FA49-4164-9069-C25704AE6B1FQ34614450-584C9774-D087-462E-ABE7-D07CED66CF80Q35532149-36CCDEC7-7F99-4FE2-A458-153C57EB0580Q35533486-EDDEDB9C-ACCD-4B4E-8870-CC9DA26AD8D0Q35644810-FCBDC794-9CF9-42F4-9012-4E53DCD62CB5Q35673461-D2FA0FA4-67F0-4A9F-A81D-B1FD06B80A5CQ35783409-9AFF2E10-737B-4D60-B8E3-AB6DE5F09687Q35816136-E380DB22-2762-4448-BD16-8A0B18D8E0E5Q35863255-B0EE9FD1-E06C-4F57-AE87-833CA8588F59Q35863416-9FAC88A1-DF7E-41D5-9306-BA4486313C23Q36093109-01C77834-0296-451F-8E72-FA8825428E59Q36093118-5102AA84-13F2-47CE-AD80-EA19436F4FE3Q36126031-5EEA50E1-3FB0-48E6-AC33-BC0963517EBAQ36126081-B4A27AC5-D8F3-4AE1-BFA7-8B29E9367793Q36128128-8E459377-FF2F-4EB3-8898-E2C139F27438Q36135318-4E4C914A-77DE-4C47-BE19-BF5833FD3243Q36146109-7894A438-2186-4D72-A90D-91E61A77E0BAQ36189631-AEA6A0DD-D29C-43D4-9EC9-64C568AA08F2Q36196758-FB4539BD-D0D1-4BC4-AAAB-745E92EFDA6AQ36215192-B73423F1-08EA-4FD2-9D3F-6FEC8054F586Q36223858-3F02E3C5-7722-4187-A7BD-9E3DAFAD2665Q36232817-52E7DE70-BACC-4FB3-817C-B4EB69E961FCQ36348408-8D7CB3E7-F96C-4AF9-8A8A-B0A07B4D62B1Q36460191-8EDE333C-3147-44EF-ACA0-50F5FE0E8358Q36461325-B469D3FB-6C92-4098-BB7D-AB7B5ECD49A9Q36462610-DB170A62-C9BC-4F56-BA9F-0B939FED0155Q36463491-4F03870B-5E68-4DC5-BE19-02889164C4CCQ36464158-5F019494-598C-4514-AE7B-D33793EE11ACQ36465078-A73DA0BF-86D5-44C2-ABE9-76329EE0EE01Q36518359-60C7615A-F703-499C-9277-7948176A1CF6Q36913772-7671E624-8DA2-4401-A7E2-0C8C591B7C76
P2860
Circulating immune complexes in the idiopathic interstitial pneumonias.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Circulating immune complexes in the idiopathic interstitial pneumonias.
@en
Circulating immune complexes in the idiopathic interstitial pneumonias.
@nl
type
label
Circulating immune complexes in the idiopathic interstitial pneumonias.
@en
Circulating immune complexes in the idiopathic interstitial pneumonias.
@nl
prefLabel
Circulating immune complexes in the idiopathic interstitial pneumonias.
@en
Circulating immune complexes in the idiopathic interstitial pneumonias.
@nl
P2093
P1476
Circulating immune complexes in the idiopathic interstitial pneumonias.
@en
P2093
Dreisin RB
Schwarz MI
Stanford RE
Theofilopoulos AN
P304
P356
10.1056/NEJM197802162980701
P407
P577
1978-02-01T00:00:00Z